{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:48:51Z","timestamp":1759366131321,"version":"build-2065373602"},"reference-count":170,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.nrl.2019.03.016","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T17:21:10Z","timestamp":1563556870000},"page":"480-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Demencias degenerativas: \u00bfun dilema de s\u00edndromes o de enfermedades?"],"prefix":"10.1016","volume":"37","author":[{"given":"A.","family":"Robles Bay\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2019.03.016_bib0855","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nrl.2019.03.016_bib0860","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer's disease: A new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurol."},{"year":"2013","series-title":"Diagnostic and Statistical Manual of Mental Disorders, 5th edition","key":"10.1016\/j.nrl.2019.03.016_bib0865"},{"key":"10.1016\/j.nrl.2019.03.016_bib0870","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0891988716656083","article-title":"Revisiting DLB diagnosis: A consideration of prodromal DLB and of the diagnostic overlap with Alzheimer disease","volume":"29","author":"McKeith","year":"2016","journal-title":"J Geriatr Psychiatry Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib0875","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1016\/j.neurobiolaging.2015.07.019","article-title":"Early stage of behavioral variant frontotemporal dementia: Clinical and neuroimaging correlates","volume":"36","author":"Borroni","year":"2015","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.nrl.2019.03.016_bib0880","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nrl.2019.03.016_bib0885","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib0890","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fneur.2018.00504","article-title":"CSF biomarkers of neurodegeneration in progressive non-fluent aphasia and other forms of frontotemporal dementia: Clues for pathomechanisms?","volume":"9","author":"K\u00f6rtvelyessy","year":"2018","journal-title":"Front Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib0895","doi-asserted-by":"crossref","first-page":"245.e9","DOI":"10.1016\/j.neurobiolaging.2017.10.016","article-title":"Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: Results from the GENFI study","volume":"62","author":"Galimberti","year":"2018","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.nrl.2019.03.016_bib0900","doi-asserted-by":"crossref","first-page":"e0171524","DOI":"10.1371\/journal.pone.0171524","article-title":"Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study","volume":"12","author":"Morimoto","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nrl.2019.03.016_bib0905","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/mds.111","article-title":"\u03b1-synuclein species as potential cerebrospinal fluid biomarkers for dementia with Lewy bodies","volume":"33","author":"Van Steenoven","year":"2018","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib0910","doi-asserted-by":"crossref","first-page":"e1619","DOI":"10.1212\/WNL.0000000000006383","article-title":"CSF sAPP\u03b2 YKL\u201440, and NfL along the ALS-FTD spectrum","volume":"91","author":"Ill\u00e1n-Gala","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.03.016_bib0915","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1007\/s12035-018-1313-4","article-title":"Cerebrospinal fluid total and phosphorylated \u03b1-synuclein in patients with Creutzfeldt-Jakob disease and synucleinopathy","volume":"56","author":"Schmitz","year":"2019","journal-title":"Mol Neurobiol."},{"key":"10.1016\/j.nrl.2019.03.016_bib0920","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/brain\/awh598","article-title":"The evolution and pathology of frontotemporal dementia","volume":"128","author":"Kertesz","year":"2005","journal-title":"Brain."},{"key":"10.1016\/j.nrl.2019.03.016_bib0925","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/2013.jamaneurol.79","article-title":"Differential diagnosis of Jakob-Creutzfeldt disease","volume":"69","author":"Paterson","year":"2012","journal-title":"Arch Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib0930","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/brain\/awx254","article-title":"Clinicopathological correlations in behavioural variant frontotemporal dementia","volume":"140","author":"Perry","year":"2017","journal-title":"Brain."},{"key":"10.1016\/j.nrl.2019.03.016_bib0935","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.03.016_bib0940","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib0945","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3233\/JAD-2012-111400","article-title":"Co-occurrence of different pathologies in dementia: Implications for dementia diagnosis","volume":"30","author":"Ech\u00e1varri","year":"2012","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrl.2019.03.016_bib0950","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer's Disease Centers, 2005-2010","volume":"71","author":"Beach","year":"2012","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib0955","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3233\/JAD-132465","article-title":"Initial diagnoses of patients ultimately diagnosed with prion disease","volume":"42","author":"Appleby","year":"2014","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrl.2019.03.016_bib0960","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00401-014-1251-9","article-title":"The widening spectrum of C9ORF72-related disease; genotype\/phenotype correlations and potential modifiers of clinical phenotype","volume":"127","author":"Cooper-Knock","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nrl.2019.03.016_bib0965","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fnagi.2015.00171","article-title":"Phenotypic heterogeneity of monogenic frontotemporal dementia","volume":"7","author":"Benussi","year":"2015","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.nrl.2019.03.016_bib0970","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jalz.2017.01.014","article-title":"Consensus classification of posterior cortical atrophy","volume":"13","author":"Crutch","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nrl.2019.03.016_bib0975","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neurobiolaging.2015.09.023","article-title":"Evaluating pathogenic dementia variants in posterior cortical atrophy","volume":"37","author":"Carrasquillo","year":"2016","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.nrl.2019.03.016_bib0980","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1590\/S0004-282X2011000300029","article-title":"Huntington's disease presenting as posterior cortical atrophy","volume":"69","author":"Caixeta","year":"2011","journal-title":"Arq Neuropsiquiatr."},{"key":"10.1016\/j.nrl.2019.03.016_bib0985","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-223108","article-title":"Down syndrome with posterior cortical atrophy","author":"Boutoleau-Bretonni\u00e8re","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.nrl.2019.03.016_bib0990","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrneurol.2009.216","article-title":"Primary progressive aphasia: Clinicopathological correlations","volume":"6","author":"Grossman","year":"2010","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib0995","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00415-014-7243-9","article-title":"Progranulin-associated PiB-negative logopenic primary progressive aphasia","volume":"261","author":"Josephs","year":"2014","journal-title":"J Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1000","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/WAD.0b013e318260ab27","article-title":"Sporadic Creutzfeldt-Jakob disease presenting as progressive nonfluent aphasia with speech apraxia","volume":"27","author":"Kobylecki","year":"2013","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00401-015-1442-z","article-title":"Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: Frontotemporal lobar degeneration associated with \u03b1-synuclein","volume":"130","author":"Aoki","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1010","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.2169\/internalmedicine.8462-16","article-title":"CSF1R mutation p.G589R and the distribution pattern of brain calcification","volume":"56","author":"Daida","year":"2017","journal-title":"Intern Med."},{"key":"10.1016\/j.nrl.2019.03.016_bib1015","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1212\/WNL.0b013e3181bd82a7","article-title":"\u201cFrontotemporoparietal\u203f dementia: Clinical phenotype associated with the c.709-1G>A PGRN mutation","volume":"73","author":"Moreno","year":"2009","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1533317507302320","article-title":"Progressive nonfluent aphasia associated with a new mutation V363I in tau gene","volume":"22","author":"Munoz","year":"2007","journal-title":"Am J Alzheimers Dis Other Demen."},{"key":"10.1016\/j.nrl.2019.03.016_bib1025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/JAD-150203","article-title":"Progressive supranuclear palsy syndrome and semantic dementia in neuropathologically proven Lewy body disease: A report of two cases","volume":"47","author":"Lagarde","year":"2015","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrl.2019.03.016_bib1030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13195-016-0219-5","article-title":"An update on semantic dementia: Genetics, imaging, and pathology","volume":"8","author":"Land\u00edn-Romero","year":"2016","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.nrl.2019.03.016_bib1035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jamda.2009.03.007","article-title":"Apathy: A common psychiatric syndrome in the elderly","volume":"10","author":"Ishii","year":"2009","journal-title":"J Am Med Dir Assoc."},{"key":"10.1016\/j.nrl.2019.03.016_bib1040","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cortex.2018.03.019","article-title":"Apathy in Alzheimer's disease and frontotemporal dementia: Distinct clinical profiles and neural correlates","volume":"103","author":"Kumfor","year":"2018","journal-title":"Cortex."},{"key":"10.1016\/j.nrl.2019.03.016_bib1045","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/mds.22843","article-title":"Apathy may herald cognitive decline and dementia in Parkinson's disease","volume":"24","author":"Dujardin","year":"2009","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1176\/appi.neuropsych.17010012","article-title":"Use of the Neuropsychiatric Inventory to characterize the course of neuropsychiatric symptoms in progressive supranuclear palsy","volume":"30","author":"Je\u013fmenica-Luki\u0107","year":"2018","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"10.1016\/j.nrl.2019.03.016_bib1055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/psyg.12054","article-title":"Corticobasal degeneration initially developing motor versus non-motor symptoms: A comparative clinicopathological study","volume":"14","author":"Ikeda","year":"2014","journal-title":"Psychogeriatrics."},{"key":"10.1016\/j.nrl.2019.03.016_bib1060","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/brain\/awv358","article-title":"Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort","volume":"139","author":"Van Mossevelde","year":"2016","journal-title":"Brain."},{"key":"10.1016\/j.nrl.2019.03.016_bib1065","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4172\/2161-0460.1000431","article-title":"Apathy in Huntington's disease: A review of the current conceptualization","volume":"8","author":"Camacho","year":"2018","journal-title":"J Alzheimers Dis Parkinsonism."},{"key":"10.1016\/j.nrl.2019.03.016_bib1070","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/jnnp-2017-316864","article-title":"Establishing diagnostic criteria for Perry syndrome","volume":"89","author":"Mishima","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrl.2019.03.016_bib1075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/alzrt141","article-title":"Neuropsychiatric features of C9orf72-associated behavioral variant frontotemporal dementia and frontotemporal dementia with motor neuron disease","volume":"4","author":"Takada","year":"2012","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.nrl.2019.03.016_bib1080","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/neup.12441","article-title":"Frontotemporal lobar degeneration due to P301L tau mutation showing apathy and severe frontal atrophy but lacking other behavioral changes: A case report and literature review","volume":"38","author":"Miki","year":"2018","journal-title":"Neuropathology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1085","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1752-1947-2-331","article-title":"Human prion disease with a G114V mutation and epidemiological studies in a Chinese family: A case series","volume":"2","author":"Ye","year":"2008","journal-title":"J Med Case Rep."},{"key":"10.1016\/j.nrl.2019.03.016_bib1090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3233\/JAD-150863","article-title":"PRNP P39L variant is a rare cause of frontotemporal dementia in Italian population","volume":"50","author":"Oldoni","year":"2016","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrl.2019.03.016_bib1095","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1212\/WNL.0b013e3181d52785","article-title":"Worldwide distribution of PSEN1 Met146Leu mutation","volume":"74","author":"Bruni","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.parkreldis.2016.12.002","article-title":"Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein gene","volume":"35","author":"Bougea","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1212\/WNL.0b013e3182815547","article-title":"Clinicopathologic differences among patients with behavioral variant frontotemporal dementia","volume":"80","author":"Mendez","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/psyg.12143","article-title":"Sexual disinhibition and dementia","volume":"16","author":"Cipriani","year":"2016","journal-title":"Psychogeriatrics."},{"key":"10.1016\/j.nrl.2019.03.016_bib1115","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awv191","article-title":"The behavioural\/dysexecutive variant of Alzheimer's disease: Clinical, neuroimaging and pathological features","volume":"138","author":"Ossenkoppele","year":"2015","journal-title":"Brain."},{"key":"10.1016\/j.nrl.2019.03.016_bib1120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1440-1789.2005.00598.x","article-title":"Argyrophilic grain disease presenting with frontotemporal dementia: A neuropathological and pathological study of an autopsied case with presenile onset","volume":"25","author":"Ishihara","year":"2005","journal-title":"Neuropathology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1125","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.neurol.2016.07.009","article-title":"Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations","volume":"172","author":"Eusebio","year":"2016","journal-title":"Rev Neurol (Paris)."},{"key":"10.1016\/j.nrl.2019.03.016_bib1130","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/13554794.2011.627345","article-title":"Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia","volume":"18","author":"Hassan","year":"2012","journal-title":"Neurocase."},{"key":"10.1016\/j.nrl.2019.03.016_bib1135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1176\/appi.ajp.2016.16020240","article-title":"Identification of two heritable cross-disorder endophenotypes for Tourette syndrome","volume":"174","author":"Darrow","year":"2017","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.nrl.2019.03.016_bib1140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1176\/jnp.2010.22.2.196","article-title":"\u201cFrontal\u203f behaviors before the diagnosis of Huntington's disease and its relationship to markers of disease progression: Evidence of early lack of awareness","volume":"22","author":"Duff","year":"2010","journal-title":"J Neuropsychiatry Clin Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.nrl.2019.03.016_bib1145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jnc.13654","article-title":"The clinical spectrum of sporadic and familial forms of frontotemporal dementia","volume":"138","author":"Woollacott","year":"2016","journal-title":"J Neurochem."},{"key":"10.1016\/j.nrl.2019.03.016_bib1150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/arclin\/acs098","article-title":"Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy","volume":"28","author":"Gerstenecker","year":"2013","journal-title":"Arch Clin Neuropsychol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000087299","article-title":"Cognitive impairment in the lateralized phenotype of corticobasal degeneration","volume":"20","author":"Moretti","year":"2005","journal-title":"Dement Cogn Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1160","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1468-1331.2012.03669.x","article-title":"Cognitive and affective impairments of a novel SCA\/MND crossroad mutation Asidan","volume":"19","author":"Abe","year":"2012","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1165","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(16)00737-6","article-title":"The frontotemporal dementia-motor neuron disease continuum","volume":"388","author":"Burrell","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.nrl.2019.03.016_bib1170","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2010.08.013","article-title":"Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss","volume":"298","author":"Kobayashi","year":"2010","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.nrl.2019.03.016_bib1175","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1468-1331.2007.01759.x","article-title":"Amyotrophic lateral sclerosis and Alzheimer's disease. Clinical and neuropathological considerations in two cases","volume":"14","author":"Rusina","year":"2007","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1180","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jns.2016.10.038","article-title":"Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of Creutzfeldt-Jakob disease (CJD)? A case report","volume":"372","author":"Yaguchi","year":"2017","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.nrl.2019.03.016_bib1185","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1212\/WNL.0000000000000778","article-title":"Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders","volume":"83","author":"Lattante","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1190","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e3181f07e0c","article-title":"Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS\/dementia","volume":"75","author":"Yan","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1195","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00401-012-1005-5","article-title":"Coexistence of Huntington's disease and amyotrophic lateral sclerosis: A clinicopathologic study","volume":"124","author":"Tada","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1200","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/17482968.2012.678365","article-title":"Combined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an I113T SOD1 mutation","volume":"13","author":"Katz","year":"2012","journal-title":"Amyotroph Lateral Scler."},{"key":"10.1016\/j.nrl.2019.03.016_bib1205","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00401-015-1431-2","article-title":"A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration","volume":"130","author":"Nakamura","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1210","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1590\/s1980-5764-2016dn1004004","article-title":"Cognitive dysfunction in hereditary spastic paraplegias and other motor neuron disorders","volume":"10","author":"Faber","year":"2016","journal-title":"Dement Neuropsychol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1215","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1582-4934.2011.01311.x","article-title":"Cerebral correlates of psychotic syndromes in neurodegenerative diseases","volume":"16","author":"Jellinger","year":"2012","journal-title":"J Cell Mol Med."},{"key":"10.1016\/j.nrl.2019.03.016_bib1220","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1017\/S0317167100013421","article-title":"Clinical overlap between Jakob-Creutzfeldt disease and Lewy body disease","volume":"39","author":"Tartaglia","year":"2012","journal-title":"Can J Neurol Sci."},{"key":"10.1016\/j.nrl.2019.03.016_bib1225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1176\/appi.neuropsych.16090168","article-title":"Psychiatric presentations of C9orf72 mutation: What are the diagnostic implications for clinicians?","volume":"29","author":"Ducharme","year":"2017","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"10.1016\/j.nrl.2019.03.016_bib1230","first-page":"73","article-title":"Juvenile neuronal ceroid lipofuscinosis (Batten disease): Current insights","volume":"6","author":"Ostergaard","year":"2016","journal-title":"Degener Neurol Neuromuscul Dis."},{"key":"10.1016\/j.nrl.2019.03.016_bib1235","doi-asserted-by":"crossref","first-page":"5320135","DOI":"10.1155\/2017\/5320135","article-title":"The association between 5HT2A T102C and behavioral and psychological symptoms of dementia in Alzheimer's disease: A meta-analysis","volume":"2017","author":"Tang","year":"2017","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.nrl.2019.03.016_bib1240","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/03007995.2017.1294054","article-title":"The hidden Niemann-Pick type C patient: Clinical niches for a rare inherited metabolic disease","volume":"33","author":"Hendriksz","year":"2017","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.nrl.2019.03.016_bib1245","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neubiorev.2014.02.010","article-title":"Familial Alzheimer's disease sustained by presenilin 2 mutations: Systematic review of literature and genotype-phenotype correlation","volume":"42","author":"Canevelli","year":"2014","journal-title":"Neurosci Biobehav Rev."},{"key":"10.1016\/j.nrl.2019.03.016_bib1250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14802\/jmd.13001","article-title":"New perspective on parkinsonism in frontotemporal lobar degeneration","volume":"6","author":"Park","year":"2013","journal-title":"J Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1255","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1590\/0004-282X20140127","article-title":"Cognition in a multiple system atrophy series of cases from Argentina","volume":"72","author":"Gatto","year":"2014","journal-title":"Arq Neuropsiquiatr."},{"issue":"Suppl 12","key":"10.1016\/j.nrl.2019.03.016_bib1260","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/mds.20547","article-title":"Parkinsonism-dementia complex of Guam","volume":"20","author":"Steele","year":"2005","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1265","doi-asserted-by":"crossref","first-page":"675","DOI":"10.33588\/rn.3807.2003542","article-title":"Heterogeneidad cl\u00ednica de la enfermedad de Alzheimer. Diferentes perfiles cl\u00ednicos pueden predecir el intervalo de progresi\u00f3n","volume":"38","author":"Mangone","year":"2004","journal-title":"Rev Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1270","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00415-012-6752-7","article-title":"MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy","volume":"260","author":"Petrovic","year":"2013","journal-title":"J Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1275","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/brain\/awf086","article-title":"Guadaloupean parkinsonism: A cluster of progressive supranuclear palsy-like tauopathy","volume":"125","author":"Caparros-Lefebvre","year":"2002","journal-title":"Brain."},{"key":"10.1016\/j.nrl.2019.03.016_bib1280","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/mds.22675","article-title":"Hereditary parkinsonism: Parkinson disease look-alikes. An algorithm for clinicians to \u201cPARK\u203f genes and beyond","volume":"24","author":"Klein","year":"2009","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1285","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1590\/S1980-57642009DN30100004","article-title":"Cognitive impairment in Wilson's disease","volume":"3","author":"Ferreira Frota","year":"2009","journal-title":"Dement Neuropsychol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.parkreldis.2017.06.004","article-title":"DCTN1-related neurodegeneration: Perry syndrome and beyond","volume":"41","author":"Konno","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1295","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/mds.21493","article-title":"Fragile X-associated tremor\/ataxia syndrome: Clinical features, genetics, and testing guidelines","volume":"22","author":"Berry-Kravis","year":"2007","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1300","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.parkreldis.2008.08.004","article-title":"Glucosidase-beta variations and Lewy body disorders","volume":"15","author":"Farrer","year":"2009","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1305","first-page":"696953","article-title":"Atypical parkinsonism revealing a late onset, rigid and akinetic form of Huntington's disease","volume":"2011","author":"Ciammola","year":"2011","journal-title":"Case Rep Neurol Med."},{"key":"10.1016\/j.nrl.2019.03.016_bib1310","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2016.11.050","article-title":"Huntington's disease like 2 presenting with isolated parkinsonism","volume":"373","author":"Vasconcellos","year":"2017","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.nrl.2019.03.016_bib1315","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.parkreldis.2016.07.015","article-title":"LRRK2 variation and dementia with Lewy bodies","volume":"31","author":"Heckman","year":"2016","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1320","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajmg.b.32505","article-title":"Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature","volume":"174","author":"Takada","year":"2017","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet."},{"key":"10.1016\/j.nrl.2019.03.016_bib1325","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ana.22424","article-title":"Clinicopathological correlations in corticobasal degeneration","volume":"70","author":"Lee","year":"2011","journal-title":"Ann Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1330","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awq123","article-title":"Does corticobasal degeneration exist? A clinicopathological re-evaluation","volume":"133","author":"Ling","year":"2010","journal-title":"Brain."},{"key":"10.1016\/j.nrl.2019.03.016_bib1335","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/13854046.2016.1259434","article-title":"Corticobasal syndrome due to sporadic Creutzfeldt-Jakob disease: A review and neuropsychological case report","volume":"31","author":"Gonz\u00e1lez","year":"2017","journal-title":"Clin Neuropsychol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1340","doi-asserted-by":"crossref","first-page":"e0153852","DOI":"10.1371\/journal.pone.0153852","article-title":"Characterization of movement disorder phenomenology in genetically proven, familial frontotemporal lobar degeneration: A systematic review and meta-analysis","volume":"11","author":"Gasca-Salas","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.nrl.2019.03.016_bib1345","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jalz.2016.08.014","article-title":"Characterizing familial corticobasal syndrome due to Alzheimer's disease pathology and PSNE1 mutations","volume":"13","author":"Lam","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nrl.2019.03.016_bib1350","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/brain\/awh265","article-title":"Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: Broadening the clinical picture to include progressive supranuclear palsy","volume":"127","author":"Paviour","year":"2014","journal-title":"Brain."},{"key":"10.1016\/j.nrl.2019.03.016_bib1355","doi-asserted-by":"crossref","first-page":"244.e9","DOI":"10.1016\/j.neurobiolaging.2017.10.010","article-title":"Beyond ALS and FTD: The phenotypic spectrum of TBK1 mutations includes PSP-like and cerebellar phenotypes","volume":"62","author":"Wilke","year":"2018","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.nrl.2019.03.016_bib1360","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1590\/S0004-282X2011000400002","article-title":"Clinical and genetic analysis of 29 Brazilian patients with Huntington's disease-like phenotype","volume":"69","author":"Rodrigues","year":"2011","journal-title":"Arq Neuropsiquiatr."},{"key":"10.1016\/j.nrl.2019.03.016_bib1365","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/mdc3.12312","article-title":"Huntington's disease, Huntington's disease look-alikes, and benign hereditary chorea. What's new?","volume":"3","author":"Schneider","year":"2016","journal-title":"Mov Disord Clin Pract."},{"key":"10.1016\/j.nrl.2019.03.016_bib1370","series-title":"Gene Reviews","article-title":"DRPLA","author":"Veneziano","year":"1993"},{"key":"10.1016\/j.nrl.2019.03.016_bib1375","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jns.2018.04.031","article-title":"A study of Huntington disease-like syndromes in black South African patients reveals a single SCA2 mutation and a unique distribution of normal alleles across five repeat loci","volume":"390","author":"Baine","year":"2018","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.nrl.2019.03.016_bib1380","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.parkreldis.2016.12.010","article-title":"New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients","volume":"36","author":"Vroegindeweij","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1385","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5334\/tohm.317","article-title":"Neuroferritinopathy: Pathophysiology, presentation, differential diagnosis and management","volume":"6","author":"Kumar","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)."},{"key":"10.1016\/j.nrl.2019.03.016_bib1390","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5334\/tohm.246","article-title":"Mutation in GM2A leads to a progressive chorea-dementia syndrome","volume":"5","author":"Salih","year":"2015","journal-title":"Tremor Other Hyperkinet Mov (N Y)."},{"key":"10.1016\/j.nrl.2019.03.016_bib1395","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.26679","article-title":"Huntington's disease-like presentation in spinocerebellar ataxia type 12","volume":"31","author":"Groppo","year":"2016","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1400","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/WNL.0000000000001521","article-title":"RNF216 mutations as a novel cause of autosomal recessive Huntington-like disorder","volume":"84","author":"Santens","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1405","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/mds.22697","article-title":"TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea","volume":"24","author":"Kovacs","year":"2009","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1410","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3233\/JAD-180018","article-title":"Frontotemporal dementia and chorea associated with a compound heterozygous TREM2 mutation","volume":"63","author":"Redaelli","year":"2008","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrl.2019.03.016_bib1415","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acn3.511","article-title":"Xeroderma pigmentosum is a definite cause of Huntington's disease-like syndrome","volume":"5","author":"Garcia-Moreno","year":"2018","journal-title":"Ann Clin Transl Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1420","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.clineuro.2017.10.039","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment in patients with multiple system atrophy","volume":"164","author":"Barcelos","year":"2018","journal-title":"Clin Neurol Neurosurg."},{"key":"10.1016\/j.nrl.2019.03.016_bib1425","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/jnnp.2006.088930","article-title":"Sporadic Creutzfeldt-Jakob disease with cerebellar ataxia at onset in the UK","volume":"77","author":"Cooper","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrl.2019.03.016_bib1430","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40673-015-0035-x","article-title":"Mitochondrial pathology in progressive cerebellar ataxia","volume":"2","author":"Bargiela","year":"2015","journal-title":"Cerebellum Ataxias."},{"key":"10.1016\/j.nrl.2019.03.016_bib1435","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/mds.26499","article-title":"Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C","volume":"31","author":"Koga","year":"2016","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1440","first-page":"135","article-title":"Mitochondrial DNA (mtDNA) diseases: Correlation of genotype to phenotype","volume":"1271","author":"Morgan-Hughes","year":"1995","journal-title":"Biochem Biophys Acta."},{"key":"10.1016\/j.nrl.2019.03.016_bib1445","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.parkreldis.2017.06.010","article-title":"Neurological phenotypes in spinocerebellar ataxia type 2: Role of mitochondrial polymorphism A10398G and other risk factors","volume":"42","author":"Monte","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1450","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.eplepsyres.2014.08.017","article-title":"Late onset Lafora disease and novel EPM2A mutations: Breaking paradigms","volume":"108","author":"Jara-Prado","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nrl.2019.03.016_bib1455","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1136\/jmg.2005.039479","article-title":"Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora's progressive myoclonic epilepsy","volume":"43","author":"Singh","year":"2006","journal-title":"J Med Genet."},{"key":"10.1016\/j.nrl.2019.03.016_bib1460","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-3639.2012.00629.x","article-title":"Degeneration of the cerebellum in Huntington's disease (HD): Possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process","volume":"23","author":"R\u00fcb","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1465","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.68.3.388","article-title":"Familial Creutzfeldt-Jakob disease with D178N-129M mutation of PRNP presenting as cerebellar ataxia without insomnia","volume":"68","author":"Taniwaki","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrl.2019.03.016_bib1470","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/brain\/124.10.1939","article-title":"CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia","volume":"124","author":"Fujigasaki","year":"2001","journal-title":"Brain."},{"key":"10.1016\/j.nrl.2019.03.016_bib1475","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1212\/01.WNL.0000125192.69777.6D","article-title":"Autonomic dysfunction in dementia with Lewy bodies","volume":"62","author":"Thaisetthawatkul","year":"2004","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1480","doi-asserted-by":"crossref","first-page":"e45451","DOI":"10.1371\/journal.pone.0045451","article-title":"The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia","volume":"7","author":"Stubendorff","year":"2012","journal-title":"PLoS ONE."},{"key":"10.1016\/j.nrl.2019.03.016_bib1485","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-140531","article-title":"The phoenix from the ashes: Cardiovascular autonomic dysfunction in behavioral variant of frontotemporal dementia","volume":"42","author":"Struhal","year":"2014","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrl.2019.03.016_bib1490","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2169\/internalmedicine.36.492","article-title":"Creutzfeldt-Jakob disease associated with autonomic nervous system dysfunction in the early stage","volume":"36","author":"Nomura","year":"1997","journal-title":"Internal Med."},{"key":"10.1016\/j.nrl.2019.03.016_bib1495","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archneur.1981.00510020072011","article-title":"Autonomic dysfunction in subacute spongiform encephalopathy","volume":"38","author":"Khurana","year":"1981","journal-title":"Arch Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1500","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/jnnp.72.6.726","article-title":"Autonomic nervous system function in Huntington's disease","volume":"72","author":"Andrich","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrl.2019.03.016_bib1505","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJMoa1214747","article-title":"A novel prion disease associated with diarrhea and autonomic neuropathy","volume":"369","author":"Mead","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nrl.2019.03.016_bib1510","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/19336896.2016.1243192","article-title":"An autopsy-verified case of FTLD-TDP type A with upper motor neuron-predominant motor neuron disease mimicking MM2-thalamic-type sporadic Creutzfeldt-Jakob disease","volume":"10","author":"Hayashi","year":"2016","journal-title":"Prion."},{"key":"10.1016\/j.nrl.2019.03.016_bib1515","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/NEN.0b013e31820cd8a4","article-title":"Comprehensive neuropathologic analysis of genetic prion disease associated with the E196K mutation in PRNP reveals phenotypic heterogeneity","volume":"70","author":"Eigenbrod","year":"2011","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1520","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000161560","article-title":"Mixed brain pathologies in dementia: The BrainNet Europe Consortium Experience","volume":"26","author":"Kovacs","year":"2008","journal-title":"Dement Geriatr Cogn Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1525","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","article-title":"Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies","volume":"67","author":"Uryu","year":"2008","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1530","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-004-0933-0","article-title":"Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: A variant of corticobasal degeneration?","volume":"109","author":"Tan","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1535","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.trci.2016.09.002","article-title":"Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development","volume":"3","author":"Rabinovici","year":"2017","journal-title":"Alzheimers Dement (N Y)."},{"key":"10.1016\/j.nrl.2019.03.016_bib1540","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14802\/jmd.10003","article-title":"Clinicopathological correlates of Lewy body disease: Fundamental issues","volume":"3","author":"Ahn","year":"2010","journal-title":"J Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1545","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00401-005-0022-z","article-title":"Coexistence of PSP and MSA: A case report and review of the literature","volume":"111","author":"Uchikado","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1550","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JHD-140111","article-title":"The co-occurrence of Alzheimer's disease and Huntington's disease: A neuropathological study of 15 elderly Huntington's disease subjects","volume":"3","author":"Davis","year":"2014","journal-title":"J Huntingtons Dis."},{"key":"10.1016\/j.nrl.2019.03.016_bib1555","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","article-title":"Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease","volume":"67","author":"Schwab","year":"2008","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1560","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/mds.22204","article-title":"Association of corticobasal degeneration and Huntington's disease: Can tau aggregates protect huntingtin toxicity?","volume":"24","author":"Caparros-Lefebvre","year":"2009","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1565","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/neup.12150","article-title":"Coexistence of mixed phenotype Creutzfeldt-Jakob disease, Lewy body disease and argyrophilic grain disease plus histological features of possible Alzheimer's disease: A multi-protein disorder in an autopsy case","volume":"35","author":"Fern\u00e1ndez-Vega","year":"2015","journal-title":"Neuropathology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1570","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/neup.12343","article-title":"Patient with rapidly evolving neurological disease with neuropathological lesions of Creutzfeldt-Jakob disease, Lewy body dementia, chronic subcortical vascular encephalopathy and meningothelial meningioma","volume":"37","author":"Vita","year":"2017","journal-title":"Neuropathology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1575","doi-asserted-by":"crossref","first-page":"216.e15","DOI":"10.1016\/j.neurobiolaging.2016.09.021","article-title":"Analysis of the prion protein gene in multiple system atrophy","volume":"49","author":"Chelban","year":"2017","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.nrl.2019.03.016_bib1580","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/neup.12429","article-title":"Neuropathological comorbidity associated with argyrophilic grain disease","volume":"38","author":"Yokota","year":"2018","journal-title":"Neuropathology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1585","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3233\/JAD-171115","article-title":"Argyrophilic grain pathology in frontotemporal lobar degeneration: Demographic, clinical, neuropathological, and genetic features","volume":"63","author":"Gil","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.nrl.2019.03.016_bib1590","first-page":"433","article-title":"[Occurrence of argyrophilic grains in multiple system atrophy: Histopathological examination of 26 autopsy cases]","volume":"51","author":"Wakabayashi","year":"1999","journal-title":"No To Shinkei."},{"key":"10.1016\/j.nrl.2019.03.016_bib1595","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/neup.12192","article-title":"Atypical sporadic CJD-MM phenotype with white matter kuru plaques associated with intranuclear inclusion body and argyrophilic grain disease","volume":"35","author":"Berghoff","year":"2015","journal-title":"Neuropathology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1600","doi-asserted-by":"crossref","first-page":"60","DOI":"10.18773\/austprescr.2015.018","article-title":"Treatment for Alzheimer's disease: Has anything changed?","volume":"38","author":"Waite","year":"2015","journal-title":"Aust Prescr."},{"key":"10.1016\/j.nrl.2019.03.016_bib1605","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11940-016-0422-5","article-title":"Progressive supranuclear palsy and corticobasal degeneration: Pathophysiology and treatment options","volume":"18","author":"Lamb","year":"2016","journal-title":"Curr Treat Options Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1610","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/DDDT.S138828","article-title":"Review of deutetrabenazine: A novel treatment for chorea associated with Huntington's disease","volume":"12","author":"Dean","year":"2018","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.nrl.2019.03.016_bib1615","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/mds.25500","article-title":"Pharmacological treatment of chorea in Huntington's disease. Good clinical practice versus evidence-based guideline","volume":"28","author":"Reilman","year":"2013","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1620","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/2015.8.FOCUS15328","article-title":"Creutzfeldt-Jakob disease: Updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy","volume":"39","author":"Manix","year":"2015","journal-title":"Neurosurg Focus."},{"key":"10.1016\/j.nrl.2019.03.016_bib1625","doi-asserted-by":"crossref","first-page":"421385","DOI":"10.1155\/2014\/421385","article-title":"Apathy in Alzheimer's disease: Any effective treatment?","volume":"2014","author":"Rea","year":"2014","journal-title":"ScientificWorldJournal."},{"key":"10.1016\/j.nrl.2019.03.016_bib1630","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1017\/S1041610217001892","article-title":"Treatment effects of Ginkgo biloba extract EGb 761\u00ae on the spectrum of behavioral and psychological symptoms of dementia: Meta-analysis of randomized controlled trials","volume":"30","author":"Savaskan","year":"2018","journal-title":"Int Psychogeriatr."},{"key":"10.1016\/j.nrl.2019.03.016_bib1635","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11940-016-0425-2","article-title":"Treatment of inappropriate sexual behavior in dementia","volume":"18","author":"De Giorgi","year":"2016","journal-title":"Curr Treat Options Neurol."},{"journal-title":"The American Psychiatric Association Practice Guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia.","year":"2016","author":"Reus","key":"10.1016\/j.nrl.2019.03.016_bib1640"},{"key":"10.1016\/j.nrl.2019.03.016_bib1645","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cns.12484","article-title":"Role of donepezil in the management of neuropsychiatric symptoms in Alzheimer's disease and dementia with Lewy bodies","volume":"22","author":"Cummings","year":"2016","journal-title":"CNS Neurosci Ther."},{"key":"10.1016\/j.nrl.2019.03.016_bib1650","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0149-2918(04)90172-5","article-title":"Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease","volume":"26","author":"Finkel","year":"2004","journal-title":"Clin Ther."},{"key":"10.1016\/j.nrl.2019.03.016_bib1655","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/14656566.2018.1445721","article-title":"Pharmacological interventions for psychosis in Parkinson's disease patients","volume":"19","author":"Friedman","year":"2018","journal-title":"Expert Opin Pharmacother."},{"key":"10.1016\/j.nrl.2019.03.016_bib1660","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0037-1602422","article-title":"Recognizing atypical parkinsonisms: \u201cRed flags\u203f and therapeutic approaches","volume":"37","author":"McFarland","year":"2017","journal-title":"Semin Neurol."},{"key":"10.1016\/j.nrl.2019.03.016_bib1665","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10072-018-3628-3","article-title":"Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson's disease","volume":"40","author":"Bianchi","year":"2019","journal-title":"Neurol Sci."},{"key":"10.1016\/j.nrl.2019.03.016_bib1670","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/mds.23738","article-title":"The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study","volume":"26","author":"Hanagasi","year":"2011","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1675","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ymgme.2009.07.003","article-title":"Miglustat in patients with Niemann-Pick disease type C (NP-C): A multicenter observational retrospective cohort study","volume":"98","author":"Pineda","year":"2009","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.nrl.2019.03.016_bib1680","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1212\/WNL.0000000000005055","article-title":"Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia","volume":"90","author":"Zesiewicz","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1685","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/mds.27344","article-title":"Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies","volume":"33","author":"Palma","year":"2018","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2019.03.016_bib1690","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: Mild cognitive impairment. Report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.03.016_bib1695","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jalz.2016.09.008","article-title":"Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia","volume":"13","author":"Simonsen","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nrl.2019.03.016_bib1700","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","article-title":"Current state of Alzheimer's fluid biomarkers","volume":"136","author":"Molinuevo","year":"2018","journal-title":"Acta Neuropathol."}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485319300817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485319300817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:13:55Z","timestamp":1759324435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485319300817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":170,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0213485319300817"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2019.03.016","relation":{},"ISSN":["0213-4853"],"issn-type":[{"type":"print","value":"0213-4853"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Demencias degenerativas: \u00bfun dilema de s\u00edndromes o de enfermedades?","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2019.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}